Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
Clinical trial NCT04093362 · TERMINATED
Trial details
- NCT number
- NCT04093362
- Sponsor
- Taiho Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2024-04-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.